{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:32:49Z","timestamp":1787139169333,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-06704-6","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T18:01:56Z","timestamp":1723917716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Hui","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nakazibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-6262","authenticated-orcid":false,"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-5538","authenticated-orcid":false,"given":"Xuebo","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-6879","authenticated-orcid":false,"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"6704_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"6704_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2008.10.008","volume":"55","author":"H Isbarn","year":"2009","unstructured":"Isbarn, H. et al. Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur. Urol. 55, 62\u201375 (2009).","journal-title":"Eur. Urol."},{"key":"6704_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20101603","volume":"437","author":"J Wesche","year":"2011","unstructured":"Wesche, J., Haglund, K. & Haugsten, E. M. Fibroblast growth factors and their receptors in cancer. Biochem. J. 437, 199\u2013213 (2011). p.","journal-title":"Biochem. J."},{"key":"6704_CR4","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-13-1550","volume":"19","author":"PG Corn","year":"2013","unstructured":"Corn, P. G., Wang, F., McKeehan, W. L. & Navone, N. Targeting fibroblast growth factor pathways in prostate cancer. Clin. Cancer Res. 19, 5856\u20135866 (2013).","journal-title":"Clin. Cancer Res."},{"key":"6704_CR5","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/0008-5472.CAN-12-3274","volume":"73","author":"F Yang","year":"2013","unstructured":"Yang, F. et al. FGFR1 is essential for prostate cancer progression and metastasis. Cancer Res. 73, 3716\u20133724 (2013).","journal-title":"Cancer Res."},{"key":"6704_CR6","doi-asserted-by":"publisher","first-page":"14839","DOI":"10.1074\/jbc.RA118.002907","volume":"293","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-kappaB signaling in prostate cancer cells. J. Biol. Chem. 293, 14839\u201314849 (2018).","journal-title":"J. Biol. Chem."},{"key":"6704_CR7","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1158\/0008-5472.CAN-17-3226","volume":"78","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. Aberrant FGFR tyrosine kinase signaling enhances the warburg effect by reprogramming LDH isoform expression and activity in prostate cancer. Cancer Res. 78, 4459\u20134470 (2018).","journal-title":"Cancer Res."},{"key":"6704_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmet.2016.07.015","volume":"24","author":"X Xue","year":"2016","unstructured":"Xue, X. et al. Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metab. 24, 447\u2013461 (2016).","journal-title":"Cell Metab."},{"key":"6704_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti, S. V. & Torti, F. M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13, 342\u2013355 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"6704_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3389\/fimmu.2017.01171","volume":"8","author":"M Jung","year":"2017","unstructured":"Jung, M., Weigert, A., Mertens, C., Rehwald, C. & Brune, B. Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2? Front. Immunol. 8, 1171 (2017).","journal-title":"Front. Immunol."},{"key":"6704_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clim.2006.06.006","volume":"121","author":"TR Daniels","year":"2006","unstructured":"Daniels, T. R., Delgado, T., Helguera, G. & Penichet, M. L. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin. Immunol. 121, 159\u2013176 (2006).","journal-title":"Clin. Immunol."},{"key":"6704_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","volume":"142","author":"MW Hentze","year":"2010","unstructured":"Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24\u201338 (2010).","journal-title":"Cell"},{"key":"6704_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1136\/gut.2006.094060","volume":"55","author":"MJ Brookes","year":"2006","unstructured":"Brookes, M. J. et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55, 1449\u20131460 (2006).","journal-title":"Gut"},{"key":"6704_CR14","doi-asserted-by":"crossref","unstructured":"Zhang, C. & Zhang, F. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities. Protein Cell 6, 88\u2013100 (2015).","DOI":"10.1007\/s13238-014-0119-z"},{"key":"6704_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1182\/blood-2007-03-076737","volume":"110","author":"D Fu","year":"2007","unstructured":"Fu, D. & Richardson, D. R. Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1\/WAF1 by iron depletion. Blood 110, 752\u2013761 (2007).","journal-title":"Blood"},{"key":"6704_CR16","doi-asserted-by":"crossref","unstructured":"Khiroya, H. et al. IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer. Eur. Respir. J. 49, 1600711 (2017).","DOI":"10.1183\/13993003.00711-2016"},{"key":"6704_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bbagen.2008.04.003","volume":"1790","author":"DR Richardson","year":"2009","unstructured":"Richardson, D. R., Kalinowski, D. S., Lau, S., Jansson, P. J. & Lovejoy, D. B. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim. Biophys. Acta 1790, 702\u2013717 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"6704_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.cej.0000228409.75976.b6","volume":"16","author":"JN Guntupalli","year":"2007","unstructured":"Guntupalli, J. N. et al. Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique. Eur. J. Cancer Prev. 16, 108\u2013115 (2007).","journal-title":"Eur. J. Cancer Prev."},{"key":"6704_CR19","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/pros.21339","volume":"71","author":"AG Sarafanov","year":"2011","unstructured":"Sarafanov, A. G. et al. Prostate cancer outcome and tissue levels of metal ions. Prostate 71, 1231\u20131238 (2011).","journal-title":"Prostate"},{"key":"6704_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/01635580701308265","volume":"58","author":"DL Ornstein","year":"2007","unstructured":"Ornstein, D. L. & Zacharski, L. R. Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells. Nutr. Cancer 58, 115\u2013126 (2007).","journal-title":"Nutr. Cancer"},{"key":"6704_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/carcin\/bgn056","volume":"29","author":"J-Y Choi","year":"2008","unstructured":"Choi, J.-Y. et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis 29, 964\u2013970 (2008).","journal-title":"Carcinogenesis"},{"key":"6704_CR22","doi-asserted-by":"publisher","first-page":"19226","DOI":"10.1073\/pnas.0700735104","volume":"104","author":"Y Xiang","year":"2007","unstructured":"Xiang, Y. et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl Acad. Sci. USA 104, 19226\u201319231 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6704_CR23","doi-asserted-by":"publisher","first-page":"e0243812","DOI":"10.1371\/journal.pone.0243812","volume":"15","author":"C Xiao","year":"2020","unstructured":"Xiao, C. et al. Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation. PloS ONE 15, e0243812 (2020).","journal-title":"PloS ONE"},{"key":"6704_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbrc.2021.08.055","volume":"575","author":"S Jung","year":"2021","unstructured":"Jung, S. et al. Depletion of ST6GALNACIII retards A549 non-small cell lung cancer cell proliferation by downregulating transferrin receptor protein 1 expression. Biochem. Biophys. Res. Commun. 575, 78\u201384 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6704_CR25","doi-asserted-by":"publisher","first-page":"29893","DOI":"10.1021\/acsomega.1c04382","volume":"6","author":"M Lodhi","year":"2021","unstructured":"Lodhi, M. et al. Probing transferrin receptor overexpression in gastric cancer mice models. ACS Omega 6, 29893\u201329904 (2021).","journal-title":"ACS Omega"},{"key":"6704_CR26","doi-asserted-by":"crossref","unstructured":"Huang, N. et al. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells. Genes Genom. 44, 637\u2013650 (2022).","DOI":"10.1007\/s13258-021-01205-w"},{"key":"6704_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature14601","volume":"525","author":"D Senyilmaz","year":"2015","unstructured":"Senyilmaz, D. et al. Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature 525, 124\u2013128 (2015).","journal-title":"Nature"},{"key":"6704_CR28","doi-asserted-by":"crossref","unstructured":"Pantopoulos, K. Iron metabolism and the IRE\/IRP regulatory system: an update. Ann. N. Y. Acad. Sci. 1012, 1\u201313 (2004).","DOI":"10.1196\/annals.1306.001"},{"key":"6704_CR29","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1073\/pnas.91.15.7321","volume":"91","author":"CC Philpott","year":"1994","unstructured":"Philpott, C. C., Klausner, R. D. & Rouault, T. A. The bifunctional iron-responsive element binding protein\/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. Proc. Natl Acad. Sci. USA 91, 7321\u20137325 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6704_CR30","doi-asserted-by":"publisher","first-page":"21645","DOI":"10.1074\/jbc.270.37.21645","volume":"270","author":"B Guo","year":"1995","unstructured":"Guo, B., Phillips, J. D., Yu, Y. & Leibold, E. A. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J. Biol. Chem. 270, 21645\u201321651 (1995).","journal-title":"J. Biol. Chem."},{"key":"6704_CR31","doi-asserted-by":"publisher","first-page":"30904","DOI":"10.1016\/S0021-9258(18)47367-X","volume":"269","author":"F Samaniego","year":"1994","unstructured":"Samaniego, F., Chin, J., Iwai, K., Rouault, T. A. & Klausner, R. D. Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J. Biol. Chem. 269, 30904\u201330910 (1994).","journal-title":"J. Biol. Chem."},{"key":"6704_CR32","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1002\/j.1460-2075.1995.tb00219.x","volume":"14","author":"K Iwai","year":"1995","unstructured":"Iwai, K., Klausner, R. D. & Rouault, T. A. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14, 5350\u20135357 (1995).","journal-title":"EMBO J."},{"key":"6704_CR33","doi-asserted-by":"publisher","first-page":"82231","DOI":"10.18632\/oncotarget.19288","volume":"8","author":"Z Deng","year":"2017","unstructured":"Deng, Z., Manz, D. H., Torti, S. V. & Torti, F. M. Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth. Oncotarget 8, 82231\u201382243 (2017).","journal-title":"Oncotarget"},{"key":"6704_CR34","doi-asserted-by":"crossref","unstructured":"Currie, C., Bjerknes, C., Myklebust, T. A. & Framroze, B. Assessing the potential of small peptides for altering expression levels of the iron-regulatory genes FTH1 and TFRC and enhancing androgen receptor inhibitor activity in in vitro prostate cancer models. Int. J. Mol. Sci. 24, 15231 (2023).","DOI":"10.3390\/ijms242015231"},{"key":"6704_CR35","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1182\/blood-2016-11-754382","volume":"130","author":"S Luscieti","year":"2017","unstructured":"Luscieti, S. et al. The actin-binding protein profilin 2 is a novel regulator of iron homeostasis. Blood 130, 1934\u20131945 (2017).","journal-title":"Blood"},{"key":"6704_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00350-9","volume":"8","author":"Y-F Wang","year":"2017","unstructured":"Wang, Y.-F. et al. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. Nat. Commun. 8, 274 (2017).","journal-title":"Nat. Commun."},{"key":"6704_CR37","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins, M. J. & Ooi, A. The Roles of NRF2 in modulating cellular iron homeostasis. Antioxid. Redox Signal. 29, 1756\u20131773 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"6704_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s43018-024-00738-9","volume":"5","author":"K Wu","year":"2024","unstructured":"Wu, K., El Zowalaty, A. E., Sayin, V. I. & Papagiannakopoulos, T. The pleiotropic functions of reactive oxygen species in cancer. Nat. Cancer 5, 384\u2013399 (2024).","journal-title":"Nat. Cancer"},{"key":"6704_CR39","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1111\/cas.15068","volume":"112","author":"H Nakamura","year":"2021","unstructured":"Nakamura, H. & Takada, K. Reactive oxygen species in cancer: current findings and future directions. Cancer Sci. 112, 3945\u20133952 (2021).","journal-title":"Cancer Sci."},{"key":"6704_CR40","doi-asserted-by":"crossref","unstructured":"Jung, M., Mertens, C., Tomat, E. & Brune, B. Iron as a central player and promising target in cancer progression. Int. J. Mol. Sci. 20, 273 (2019).","DOI":"10.3390\/ijms20020273"},{"key":"6704_CR41","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1074\/jbc.271.9.4900","volume":"271","author":"BR Henderson","year":"1996","unstructured":"Henderson, B. R., Menotti, E. & K\u00fchn, L. C. Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences. J. Biol. Chem. 271, 4900\u20134908 (1996).","journal-title":"J. Biol. Chem."},{"key":"6704_CR42","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/MCB.26.6.2373-2386.2006","volume":"26","author":"KA O\u2019Donnell","year":"2006","unstructured":"O\u2019Donnell, K. A. et al. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol. Cell. Biol. 26, 2373\u20132386 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"6704_CR43","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1101\/gad.299388.117","volume":"31","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2. Genes Dev. 31, 1243\u20131256 (2017).","journal-title":"Genes Dev."},{"key":"6704_CR44","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","volume":"11","author":"J Liu","year":"2019","unstructured":"Liu, J., Zhang, C., Hu, W. & Feng, Z. Tumor suppressor p53 and metabolism. J. Mol. cell Biol. 11, 284\u2013292 (2019).","journal-title":"J. Mol. cell Biol."},{"key":"6704_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molcel.2020.02.011","volume":"78","author":"H Wang","year":"2020","unstructured":"Wang, H. et al. FBXL5 regulates IRP2 stability in iron homeostasis via an oxygen-responsive [2Fe2S] cluster. Mol. Cell 78, 31\u201341.e5 (2020).","journal-title":"Mol. Cell"},{"key":"6704_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/(SICI)1097-0045(19970515)31:3<153::AID-PROS2>3.0.CO;2-M","volume":"31","author":"S Beshara","year":"1997","unstructured":"Beshara, S. et al. Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin. Prostate 31, 153\u2013160 (1997).","journal-title":"Prostate"},{"key":"6704_CR47","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0002-9343(99)80015-1","volume":"98","author":"MH Lee","year":"1995","unstructured":"Lee, M. H. & Means, R. T. Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am. J. Med. 98, 566\u2013571 (1995).","journal-title":"Am. J. Med."},{"key":"6704_CR48","first-page":"916","volume":"8","author":"Y Shen","year":"2018","unstructured":"Shen, Y. et al. Transferrin receptor 1 in cancer: a new sight for cancer therapy. Am. J. Cancer Res. 8, 916\u2013931 (2018).","journal-title":"Am. J. Cancer Res."},{"key":"6704_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"6704_CR50","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/ijc.33922","volume":"150","author":"Z Fan","year":"2022","unstructured":"Fan, Z. et al. Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells. Int. J. Cancer 150, 1525\u20131536 (2022).","journal-title":"Int. J. Cancer"},{"key":"6704_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/01.cej.0000228409.75976.b6","volume":"16","author":"JNR Guntupalli","year":"2007","unstructured":"Guntupalli, J. N. R. et al. Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique. Eur. J. Cancer Prev. 16, 108\u2013115 (2007).","journal-title":"Eur. J. Cancer Prev."},{"key":"6704_CR52","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1541-7786.MCR-14-0074","volume":"12","author":"IRD Johnson","year":"2014","unstructured":"Johnson, I. R. D. et al. Altered endosome biogenesis in prostate cancer has biomarker potential. Mol. Cancer Res. 12, 1851\u20131862 (2014).","journal-title":"Mol. Cancer Res."},{"key":"6704_CR53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0022-5347(17)39970-6","volume":"143","author":"HN Keer","year":"1990","unstructured":"Keer, H. N. et al. Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J. Urol. 143, 381\u2013385 (1990).","journal-title":"J. Urol."},{"key":"6704_CR54","doi-asserted-by":"crossref","unstructured":"Zapa\u0142a, P. et al. E-Cadherin, Integrin Alpha2 (Cd49b), and Transferrin Receptor-1 (Tfr1) are promising immunohistochemical markers of selected adverse pathological features in patients treated with radical prostatectomy. J. Clin. Med. 10, 5587 (2021).","DOI":"10.3390\/jcm10235587"},{"key":"6704_CR55","first-page":"2176","volume":"13","author":"J Lang","year":"2019","unstructured":"Lang, J. et al. Targeted Co-delivery of the iron chelator deferoxamine and a HIF1\u03b1 inhibitor impairs pancreatic tumor growth. ACS Nano 13, 2176\u20132189 (2019).","journal-title":"ACS Nano"},{"key":"6704_CR56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/cas.14607","volume":"112","author":"K Komoto","year":"2021","unstructured":"Komoto, K. et al. Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine. Cancer Sci. 112, 410\u2013421 (2021).","journal-title":"Cancer Sci."},{"key":"6704_CR57","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1158\/0008-5472.CAN-20-1628","volume":"81","author":"C Sandoval-Acu\u00f1a","year":"2021","unstructured":"Sandoval-Acu\u00f1a, C. et al. Targeting mitochondrial iron metabolism suppresses tumor growth and metastasis by inducing mitochondrial dysfunction and mitophagy. Cancer Res. 81, 2289\u20132303 (2021).","journal-title":"Cancer Res."},{"key":"6704_CR58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-9966-30-34","volume":"30","author":"Z Li","year":"2011","unstructured":"Li, Z., Tanaka, H., Galiano, F. & Glass, J. Anticancer activity of the iron facilitator LS081. J. Exp. Clin. Cancer Res. 30, 34 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6704_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cmet.2011.07.011","volume":"14","author":"T Moroishi","year":"2011","unstructured":"Moroishi, T., Nishiyama, M., Takeda, Y., Iwai, K. & Nakayama, K. I. The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. Cell Metab. 14, 339\u2013351 (2011).","journal-title":"Cell Metab."},{"key":"6704_CR60","doi-asserted-by":"publisher","first-page":"16529","DOI":"10.1074\/jbc.270.28.16529","volume":"270","author":"B Guo","year":"1995","unstructured":"Guo, B., Brown, F. M., Phillips, J. D., Yu, Y. & Leibold, E. A. Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels. J. Biol. Chem. 270, 16529\u201316535 (1995).","journal-title":"J. Biol. Chem."},{"key":"6704_CR61","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1128\/MCB.24.3.954-965.2004","volume":"24","author":"J Wang","year":"2004","unstructured":"Wang, J. et al. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell. Biol. 24, 954\u2013965 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"6704_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2005.05.027","volume":"19","author":"H Ishikawa","year":"2005","unstructured":"Ishikawa, H. et al. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol. Cell 19, 171\u2013181 (2005).","journal-title":"Mol. Cell"},{"key":"6704_CR63","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/imr.12307","volume":"266","author":"L Elton","year":"2015","unstructured":"Elton, L., Carpentier, I., Verhelst, K., Staal, J. & Beyaert, R. The multifaceted role of the E3 ubiquitin ligase HOIL-1: beyond linear ubiquitination. Immunol. Rev. 266, 208\u2013221 (2015).","journal-title":"Immunol. Rev."},{"key":"6704_CR64","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.1176326","volume":"326","author":"AA Salahudeen","year":"2009","unstructured":"Salahudeen, A. A. et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326, 722\u2013726 (2009).","journal-title":"Science"},{"key":"6704_CR65","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.1176333","volume":"326","author":"AA Vashisht","year":"2009","unstructured":"Vashisht, A. A. et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 326, 718\u2013721 (2009).","journal-title":"Science"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06704-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:03:50Z","timestamp":1723921430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06704-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6704"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06704-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"1 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval of the research protocol by an Institutional Reviewer Board: The experimental procedures for plasmid construction were approved by the Genetically Modified Organisms Safety Committee of Wenzhou Medical University. Animal Studies: The male BALB\/c nude mice were housed under the Program of Animal Resources of the Wenzhou Medical University in accordance with the principles and procedures of the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}}],"article-number":"1011"}}